000 01269 a2200373 4500
005 20250517142152.0
264 0 _c20180713
008 201807s 0 0 eng d
022 _a1179-1926
024 7 _a10.1007/s40262-017-0519-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKing, Jennifer R
245 0 0 _aClinical Pharmacokinetics of Dasabuvir.
_h[electronic resource]
260 _bClinical pharmacokinetics
_c10 2017
300 _a1115-1124 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _a2-Naphthylamine
650 0 4 _aAnimals
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aDrug Interactions
_xphysiology
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHepacivirus
_xdrug effects
650 0 4 _aHepatitis C, Chronic
_xblood
650 0 4 _aHumans
650 0 4 _aLiver Diseases
_xblood
650 0 4 _aSulfonamides
_xadministration & dosage
650 0 4 _aUracil
_xadministration & dosage
700 1 _aZha, Jiuhong
700 1 _aKhatri, Amit
700 1 _aDutta, Sandeep
700 1 _aMenon, Rajeev M
773 0 _tClinical pharmacokinetics
_gvol. 56
_gno. 10
_gp. 1115-1124
856 4 0 _uhttps://doi.org/10.1007/s40262-017-0519-3
_zAvailable from publisher's website
999 _c26934194
_d26934194